Amol P.

Amol P. is an accomplished Associate Director of Statistical Programming at Akero Therapeutics, Inc., with 19 years of specialized expertise in statistical programming for clinical trials. They lead programming strategies that ensure regulatory submissions and the development of innovative treatments for patients with serious metabolic diseases. Amol's career includes significant roles at prominent biotechnology companies, where they managed complex vendor relationships and built high-performing teams. They have played a key role in supporting FDA approvals and have continuously pursued advanced training in emerging technologies, illustrating a commitment to merging traditional statistical programming with modern data science innovations.